American Association for Clinical Chemistry
Better health through laboratory medicine
2006 Comment Letters

Below is a listing of AACC's most recent comment letters. If you have questions regarding AACC's positions, please contact AACC Government Affairs at (800) 892-1400.

09/20/06 AACC provided comments to CMS regarding proposed changes to the physician fee schedule
09/20/06 AACC submitted comments to CMS regarding it 2007 payment determinations
08/28/06 AACC wrote to NIH endorsing its National Children's Study
08/24/06 AACC submitted comments to OMB on the proposed competitive demonstration project submission form
06/20/06 AACC wrote to Representative Schwarz endorsing his legislation, H.R.5358, the Science and Mathematicss Education Competitiveness Act.
06/12/06 AACC wrote to CMS to express its views on the competitive bidding demonstration project and the form that will be used by bidders.
06/12/06 AACC sent comments to NCCI regarding the Medically Unbelievable Edits proposal.
05/23/06 AACC sent comments to the FDA regardings its new policy regarding the use of excess specimens for clinical resource.
05/23/06 AACC wrote to Senators DeWine and Dodd endorsing S.2663, the Newborn Screening Saves Lives Act.
03/24/06 AACC wrote to House and Senate Appropriators endorsing $69 million for the National Children's Study.
02/10/06 AACC provided comments to the FDA regarding its draft guidance on the CLIA waiver criteria.
01/30/06 AACC commented to OMB regarding forthcoming FDA guidance document on the use of excess specimens